JPRN-UMIN000001080
Completed
未知
Jikei Nateglinide and Arbs for Vascular Intervention Study - J-NAVI
tokyo jikei university school of medicine0 sites100 target enrollmentMarch 15, 2008
Conditionstype 2 diabetes mellitus
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- type 2 diabetes mellitus
- Sponsor
- tokyo jikei university school of medicine
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)Patients with severe heart disease 2\)Patients with severe liver dysfunction 3\)Patients with poor glycemic controls(glycated hemoglobin \>8\.0%) 4\)Drug allegy to ARB 5\)Patients with hemodialysis 6\)Pregnant or possibility of pregnant 7\)Patients that treated with pioglitazone within 6 months 8\)Patients with renal dysfunction(serum creatinine\>3\.0mg/dl) 9\)Other patients judged inappropriate for the study by the investigators
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Kanagawa intravenous and endovascular treatment of acute ischemic stroke registryischemic strokeJPRN-UMIN000030554St. Marianna University Toyoko Hospital600
Completed
Not Applicable
Endovascular Treatment for Infra-inguinal Vessel, in patients with critical limb ischemia, - A Prospective, Multi-center, 12 month follow-up Registry in JapanPatients with peripheral artery disease (PAD) associated with critical limbs ischemia (CLI)JPRN-UMIN000002830OLIVE Registry Study Group300
Completed
Not Applicable
Japanese BElow-the-knee Artery Treatment trial for critical limb ischemiaCritical Limb IschemiaJPRN-UMIN000004917Kansai Rosai Hospital, Cardiovascular Center500
Completed
Not Applicable
Japanese BElow-the-knee Artery Treatment trial for critical limb ischemia; the angiographic follow up @ 3 monthsCritical Limb IschemiaJPRN-UMIN000006488Kansai Rosai Hospital, Cardiovascular Center100
Completed
Not Applicable
Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI Study)ISRCTN44258879niversity of Ottawa Heart Institute (Canada)170